Chrystal Paulos to Receptor, Anaphylatoxin C5a
This is a "connection" page, showing publications Chrystal Paulos has written about Receptor, Anaphylatoxin C5a.
Connection Strength
0.034
-
Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy. Transplantation. 2017 04; 101(4):e75-e85.
Score: 0.034